Royalty Pharma
(RPRX)
undefined
undefined%
At close: undefined
26.10
1.40%
After-hours Jan 06, 2025, 05:05 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | 1.13B | 230.06M | 1.24B | 1.70B | 2.46B | 1.52B | 1.34B |
| Depreciation & Amortization | n/a | 5.67M | 23.00M | 23.06M | 23.92M | 33.27M | 33.27M |
| Stock-Based Compensation | 2.36M | 2.17M | 2.44M | 5.43M | n/a | n/a | n/a |
| Other Working Capital | 3.19B | 30.38M | -11.74M | -1.88B | -1.67B | -1.56B | -1.48B |
| Other Non-Cash Items | -1.35B | 1.87B | 2.29B | 2.12B | 855.40M | 1.63B | 1.52B |
| Deferred Income Tax | n/a | n/a | -1.52B | 65.49M | n/a | n/a | n/a |
| Change in Working Capital | 3.20B | 32.66M | -16.32M | -1.88B | -1.67B | -1.56B | -1.48B |
| Operating Cash Flow | 2.99B | 2.14B | 2.02B | 2.03B | 1.67B | 1.62B | 1.42B |
| Capital Expenditures | n/a | 2.04B | 523.00K | 2.20B | -1.72B | 269.59M | -2.29B |
| Acquisitions | -12.54M | -9.90M | -34.85M | -40.00M | -27.04M | -24.17M | -2.00M |
| Purchase of Investments | -2.12B | -2.57B | -3.59B | -3.94B | -2.36B | -422.40M | -2.30B |
| Sales Maturities Of Investments | 25.83M | 1.55B | 1.78B | 1.20B | 524.55M | 750.00M | 600.00M |
| Other Investing Acitivies | 29.44M | -2.04B | -18.60M | -2.18B | 1.47B | -269.59M | 115.00M |
| Investing Cash Flow | -2.07B | -1.03B | -1.87B | -2.76B | -2.12B | 303.42M | -1.59B |
| Debt Repayment | -1.00B | n/a | 1.27B | 680.63M | -294.00M | -294.00M | 907.00M |
| Common Stock Repurchased | -304.76M | n/a | n/a | n/a | -4.27M | n/a | n/a |
| Dividend Paid | -358.33M | -333.32M | -285.18M | -397.84M | -739.28M | -814.36M | -735.17M |
| Other Financial Acitivies | -485.67M | -611.53M | -602.24M | -704.36M | -154.08M | -270.74M | -295.08M |
| Financial Cash Flow | -2.15B | -944.86M | 385.11M | 1.49B | -1.19B | -1.38B | -123.25M |
| Net Cash Flow | -1.23B | 169.70M | 532.37M | 763.00M | -1.64B | 542.64M | -292.65M |
| Free Cash Flow | 2.99B | 4.19B | 2.02B | 4.23B | -54.05M | 1.89B | -872.39M |